EQS-News: PJSC Mechel : Mechel Reports Decisions of its Board of Directors
vom 25.05.2021, 11:00 Uhr
Bild: pixabay.com
PJSC Mechel : Mechel Reports Decisions of its Board of Directors
25.05.2021 / 12:00 MSK
MECHEL REPORTS DECISIONS OF ITS BOARD OF DIRECTORS
Moscow, Russia - May 25, 2021 - Mechel PAO (NYSE: MTL, MOEX: MTLR), a leading Russian mining and metals company, announces the decisions made by its Board of Directors at a meeting held on May 24, 2021.
The Board of Directors made the following recommendations to the general meeting of Mechel PAO s shareholders:
- not to pay an annual dividend with respect to ordinary shares;
- to pay an annual dividend of 1.17 rubles per one preferred share.
Share this article
Share this article
ST. LOUIS, Mo., May 25, 2021 /PRNewswire/ Benson Hill, Inc. a food tech company unlocking the natural genetic diversity of plants with its cutting-edge food innovation engine, today announced Matt Crisp, CEO, will participate in a discussion with David Lee, AppHarvest President and Benson Hill Board Member at the upcoming Crusonia Conversations, Sustainable Food Technology: Driving the Plant-Based Food Revolution, on May 26, 2021, Noon CT. This event follows Benson Hill s recent announcement that it will become publicly listed through a business combination with Star Peak Corp II (NYSE: STPC).
Upcoming Crusonia Conversations, “Sustainable Food Technology: Driving the Plant-Based Food Revolution,” on May 26, 2021, Noon CT.
Johnson & Johnson to Host Live ESG Investor Update Webcast
Johnson & Johnson announced today it will host an Environmental, Social and Governance Investor Update Webcast at 8:00 a.m. on June 23, 2021 . The webcast will discuss progress made in advancing a healthier world for all and will outline the Company’s ESG management approach around its priority ESG topics. Leaders from across the enterprise will share progress the Company has made in each of their respective areas …
Johnson & Johnson (NYSE: JNJ) announced today it will host an Environmental, Social and Governance (ESG) Investor Update Webcast at 8:00 a.m. (Eastern Time) on June 23, 2021 . The webcast will discuss progress made in advancing a healthier world for all and will outline the Company’s ESG management approach around its priority ESG topics. Leaders from across the enterprise will share progress the Company has made in each of their respective areas to help drive long-term value creation and strengthen our ab
Algoma Steel and Legato Merger Corp Sign Definitive Merger Agreement prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
(0)
The pivotal Phase 3 OPTIMUM trial showed treatment with ponesimod led to a 30.5 percent reduction in annual relapse rate (p1
The OPTIMUM trial is the first of its kind to compare head-to-head two oral disease modifying treatments (DMTs) in RMS
Approval follows more than 10 years of cumulative data from Phase 2 and Phase 3 studies demonstrating ponesimod s efficacy and safety
1,2,3
Approval builds on Janssen s deep-rooted history in neuroscience and reinforces Company commitment to addressing unmet needs for neurological conditions like MS
Janssen, the Pharmaceutical Companies of Johnson Johnson, announced today that the European Commission (EC) has approved PONVORY ?
(ponesimod) for the treatment of adult patients with relapsing multiple sclerosis (RMS) with active disease defined by clinical or imaging features.